Einstein-Montefiore Researcher Will Test Nanoparticles Against Pancreatic Cancer

A $16-million grant from the National Cancer Institute will utilize specialized expertise developed by Steven Libutti, M.D., professor and vice chair of surgery at Albert Einstein College of Medicine of Yeshiva University and Montefiore, the University Hospital and Academic Medical Center for Einstein. The research - carried out by a group of institutions, including Einstein, that comprise the Texas Center for Cancer Nanomedicine - could lead to novel ways to diagnose and treat pancreatic cancer using nanoparticles.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews